SZSanduo Zheng

Sanduo Zheng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sanduo Zheng has a total of 74 co-authors. Here are the top co-authors by number of shared publications:

  • Sijia Chen

    Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University

    5 shared publications
  • Yingying Nie

    College of Life Sciences, Beijing Normal University

    4 shared publications
  • Jiahao Ma

    Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing 100084, China; National Institute of Biological Sciences, Beijing 102206, China

    3 shared publications
  • Niu Huang

    Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing 102206, China

    3 shared publications
  • Wentong Jiang

    National Institute of Biological Sciences

    3 shared publications
  • Xiao Teng

    Tsinghua Institute of Multidisciplinary Biomedical Research, Tsinghua University, Beijing, China

    3 shared publications

Latest Publications

  • Open Access

    Molecular-dynamics-simulation-guided directed evolution of flavoenzymes for atroposelective desaturation

    by Hong-Ning Yin, Zhao Chen, Xiang Zhao, Zihan Liu, Feng Yu, Sanduo Zheng, Niu Huang, Zhen Liu


  • KCTD Family: Emerging Regulators of GPCR Biased Signaling

    by Wentong Jiang, Sanduo Zheng

    G protein-coupled receptors (GPCRs) engage multiple transducers to regulate distinct physiological processes. These transducers include various G proteins subtypes, GPCR kinases (GRKs), and β-arrestins. In addition to promoting receptor desensitization, β-arrestins serve as scaffolds for signaling via non-G protein pathways. Biased signaling enables GPCRs to selectively engage specific transducers, typically through different conformational states of GPCRs. While significant focus has been placed on developing biased ligands that preferentially activate specific G proteins or β-arrestins, the strategy focused on modulating particular G protein subunits (Gα versus βγ) remains underexplored. Recently, members of the KCTD (potassium channel tetramerization domain-containing) family have emerged as critical regulators of GPCR signaling, particularly through their roles in mediating Gβγ degradation or uncoupling Gβγ from downstream effectors. This ability positions the KCTD family as potential targets for selectively modulating Gβγ signaling with minimal impact on Gα-mediated pathways. In this chapter, we introduce the KCTD family, summarize current knowledge of their role in GPCR signaling regulation, and highlight unsolved questions in existing models, along with directions for future research.


  • SARM1 activation promotes axonal degeneration via a two-step phase transition

    by Wenbin Zhang, Qinyi Zhou, Jun Zhang, Jiachen Wang, Qingcui Wu, Sanduo Zheng, Xiaodong Wang

    SARM1 is a key executioner of axonal degeneration, acting through NAD⁺ depletion by NADase activity of its TIR domain. Although normally autoinhibited, SARM1 becomes activated in response to axonal damage; however, the underlying mechanism remains unclear. Here, using a class of pyridine-containing compounds that trigger SARM1-dependent axon degeneration, we uncover a two-step activation process. First, NMN primes the base exchange activity of SARM1, generating covalent adducts between ADP-ribose (an NAD⁺ hydrolysis product) and the compounds. These ADP-ribose conjugates then serve as molecular glues to promote the assembly of superhelical SARM1 filaments, in which TIR domains adopt an active configuration. After reaching solubility limits, these filaments condense into stable, phase-separated assemblies with full enzymatic activity. Unexpectedly, several clinical-stage SARM1 inhibitors targeting its TIR domain also form such adducts, paradoxically promoting its activation. These findings reveal a molecular mechanism that spatially restricts SARM1 activation to damaged axons and offer new guidance for therapeutic strategies targeting SARM1.


  • Open Access

    ELAPOR1 is a copper-dependent tethering factor driving proacrosomal vesicle fusion during acrosome biogenesis

    by Tianyu Shao, Jiahao Ma, Xinshui Tan, Hongcheng Shan, Dan Xu, Kexin Zhang, Sanduo Zheng, Fengchao Wang

    The acrosome is a crucial organelle essential for sperm function and male fertility. During acrosome biogenesis, numerous proacrosomal vesicles (PAVs) are transported to the concave region of the nuclear membrane and fuse to form the acrosome. However, the mechanisms governing the fusion of PAVs to form the acrosome remain poorly understood. Here, we identify endosome-lysosome associated apoptosis and autophagy regulator 1 (ELAPOR1), a conserved protein, as a key factor in PAVs fusion during acrosome biogenesis. Male mice lacking Elapor1 ( Elapor1 −/− ) are infertile, exhibiting defective acrosome biogenesis and a globozoospermia-like phenotype. Using cryo-electron microscopy revealed that ELAPOR1 forms a square planar homodimer in cis, which assembles into a trans-tetramer via head-to-head homophilic interactions dependent on copper chelation. Notably, ELAPOR1 exhibits dual membrane orientation, with a predicted N in − C out topology and a noncanonical N out − C in topology in vesicles. The noncanonical N out − C in topology enables ELAPOR1 to function as a tethering factor bridging vesicles through head-to-head homophilic interactions. A mutant ELAPOR1 (ELAPOR1 4HA ) incapable of copper chelation forms cis homodimers but fails to mediate homophilic interactions in vitro, leading to defective PAVs fusion in mice, phenocopying the Elapor1 -deficient mice. Additionally, ELAPOR1 was shown to interact with soluble N-ethylmaleimide sensitive factor attachment protein receptors protein STX12. Conditional knockout of Stx12 in germ cells resulted in similar defects in acrosome biogenesis. Collectively, our findings suggest that ELAPOR1 functions as a tethering factor that regulates PAV fusion through a copper-dependent mechanism.


  • Open Access

    Allosteric modulation of dimeric GPR3 by ligands in the dimerization interface

    by Zeming Qiu, Wei Wang, Yingying Nie, Junxiang Lin, Beimeng Zhang, Haonan Xing, Sanduo Zheng

    Class C G-protein coupled receptors (GPCRs) are widely recognized to function as a dimer, whereas the existence, molecular mechanisms and functional importance of dimerization in class A GPCRs remain poorly explored. GPR3, GPR6 and GPR12 are closely related to cannabinoid receptors, and are associated with neurogenerative diseases such as Parkinson’s and Alzheimer’s diseases. Here, we determined cryo-EM structures of GPR3-Gs complex in the active state and GPR3 alone in the inactive state. We observe that GPR3 forms symmetric dimers in both states, with the dimerization interface primarily involving TM5 and TM6. Upon activation, GPR3 undergoes an outward movement of TM6 and an inward movement of TM7, alongside stabilization of helix 8, which is disordered in the inactive state. Functionally, GPR3 dimerization attenuates Gs signaling. Furthermore, we identify AF64394 as a negative allosteric modulator that targets the GPR3 dimerization interface and allosterically shifts the α-helical structure of ICL2 into a random coil structure, thereby impairing Gs coupling. Our findings provide structural and mechanistic insights into class A GPCR dimerization, offering potential therapeutic strategies targeting the dimerization interface of these receptors.


  • Open Access

    Allosteric modulation of dimeric GPR3 by ligands in the dimerization interface

    by Zeming Qiu, Wei Wang, Yingying Nie, Junxiang Lin, Beimeng Zhang, Haonan Xing, Sanduo Zheng

    Class C G-protein coupled receptors (GPCRs) are widely recognized to function as a dimer, whereas the existence, molecular mechanisms and functional importance of dimerization in class A GPCRs remain poorly explored. GPR3, GPR6 and GPR12 are closely related to cannabinoid receptors, and are associated with neurogenerative diseases such as Parkinson’s and Alzheimer’s diseases. Here, we determined cryo-EM structures of GPR3-G s complex in the active state and GPR3 alone in the inactive state. We observe that GPR3 forms symmetric dimers in both states, with the dimerization interface primarily involving TM5 and TM6. Upon activation, GPR3 undergoes an outward movement of TM6 and an inward movement of TM7, alongside stabilization of helix 8, which is disordered in the inactive state. Functionally, GPR3 dimerization attenuates G s signaling. Furthermore, we identify AF64394 as a negative allosteric modulator that targets the GPR3 dimerization interface and allosterically shifts the α-helical structure of ICL2 into a random coil structure, thereby impairing G s coupling. Our findings provide structural and mechanistic insights into class A GPCR dimerization, offering potential therapeutic strategies targeting the dimerization interface of these receptors.

  • Open Access

    Stepwise activation of SARM1 for cell death and axon degeneration revealed by a biosynthetic NMN mimic

    by Yinpin Huang, Jun Zhang, Wenbin Zhang, Jie Chen, Sijia Chen, Qincui Wu, Sanduo Zheng, Xiaodong Wang

    Axon degeneration, driven by the NAD + hydrolyzing enzyme SARM1, is an early pathological hallmark of numerous neurodegenerative diseases. SARM1 exists in an inactive form and is activated following nerve injury. However, the precise molecular mechanism underlying SARM1 activation remains to be fully elucidated. In this study, we report the identification of a potent proactivator of SARM1, G10, which is converted into a direct activator (M1) by the enzyme nicotinamide phosphoribosyltransferase. Cryoelectron microscopy structures of SARM1 bound to M1, as well as to M1 and a nonhydrolyzable NAD + analog (1AD), captured two intermediate activation states and the fully active state, revealing a stepwise mechanism of SARM1 activation. Further, introducing a disulfide bond to prevent conformational transitions between the two intermediate states mediated by M1 stabilized SARM1 in its inactive form and blocked M1-induced cell death. Together, these findings propose a sequential, stepwise activation model for SARM1 and offer a framework for developing potential SARM1 inhibitors for the treatment of neurodegenerative diseases.


  • Top Cited Papers

    Zinc transporter 1 functions in copper uptake and cuproptosis

    by Yehua Li, Jiahao Ma, Rui Wang, Yuanhanyu Luo, Sanduo Zheng, Xiaodong Wang


  • Open Access

    Specific binding of GPR174 by endogenous lysophosphatidylserine leads to high constitutive Gs signaling

    by Yingying Nie, Zeming Qiu, Sijia Chen, Zhao Chen, Xiaocui Song, Yan Ma, Niu Huang, Jason G. Cyster, Sanduo Zheng

    Many orphan G protein-coupled receptors (GPCRs) remain understudied because their endogenous ligands are unknown. Here, we show that a group of class A/rhodopsin-like orphan GPCRs including GPR61, GPR161 and GPR174 increase the cAMP level similarly to fully activated D1 dopamine receptor (D1R). We report cryo-electron microscopy structures of the GPR61‒Gs, GPR161‒Gs and GPR174‒Gs complexes without any exogenous ligands. The GPR174 structure reveals that endogenous lysophosphatidylserine (lysoPS) is copurified. While GPR174 fails to respond to exogenous lysoPS, likely owing to its maximal activation by the endogenous ligand, GPR174 mutants with lower ligand binding affinities can be specifically activated by lysoPS but not other lipids, in a dose-dependent manner. Moreover, GPR174 adopts a non-canonical Gs coupling mode. The structures of GPR161 and GPR61 reveal that the second extracellular loop (ECL2) penetrates into the orthosteric pocket, possibly contributing to constitutive activity. Our work definitively confirms lysoPS as an endogenous GPR174 ligand and suggests that high constitutive activity of some orphan GPCRs could be accounted for by their having naturally abundant ligands.


  • Open Access

    Structural basis for the ubiquitination of G protein βγ subunits by KCTD5/Cullin3 E3 ligase

    by Wentong Jiang, Wei Wang, Yinfei Kong, Sanduo Zheng

    G protein–coupled receptor (GPCR) signaling is precisely controlled to avoid overstimulation that results in detrimental consequences. Gβγ signaling is negatively regulated by a Cullin3 (Cul3)–dependent E3 ligase, KCTD5, which triggers ubiquitination and degradation of free Gβγ. Here, we report the cryo–electron microscopy structures of the KCTD5-Gβγ fusion complex and the KCTD7-Cul3 complex. KCTD5 in pentameric form engages symmetrically with five copies of Gβγ through its C-terminal domain. The unique pentameric assembly of the KCTD5/Cul3 E3 ligase places the ubiquitin-conjugating enzyme (E2) and the modification sites of Gβγ in close proximity and allows simultaneous transfer of ubiquitin from E2 to five Gβγ subunits. Moreover, we show that ubiquitination of Gβγ by KCTD5 is important for fine-tuning cyclic adenosine 3´,5´-monophosphate signaling of GPCRs. Our studies provide unprecedented insights into mechanisms of substrate recognition by unusual pentameric E3 ligases and highlight the KCTD family as emerging regulators of GPCR signaling.